Identification | More | [Name]
2-Bromo-5-methylbenzenamine | [CAS]
53078-85-6 | [Synonyms]
2-BROMO-5-METHYLANILINE 2-bromo-5-methylbenzenamine 2-BROMO-5-METHYL-PHENYLAMINE CHEMPACIFIC 39968 | [Molecular Formula]
C7H8BrN | [MDL Number]
MFCD01806278 | [Molecular Weight]
186.05 | [MOL File]
53078-85-6.mol |
Chemical Properties | Back Directory | [Melting point ]
46°C | [Boiling point ]
130°C/16mmHg(lit.) | [density ]
1.486 g/mL at 25 °C | [refractive index ]
n20/D 1.603 | [Fp ]
110 °C | [storage temp. ]
2-8°C | [form ]
Solid | [pka]
2.66±0.10(Predicted) | [color ]
White to Orange to Green | [InChI]
InChI=1S/C7H8BrN/c1-5-2-3-6(8)7(9)4-5/h2-4H,9H2,1H3 | [InChIKey]
QTAQWOXSUFGGKH-UHFFFAOYSA-N | [SMILES]
C1(N)=CC(C)=CC=C1Br | [CAS DataBase Reference]
53078-85-6(CAS DataBase Reference) |
Hazard Information | Back Directory | [Chemical Properties]
Brown crystal | [Uses]
2-Bromo-5-methylbenzenamine is an intermediate for synthesizing new indole anticancer drugs, antihypertensive drug reserpine, triptan drugs for treating migraine, indomethacin for treating rheumatism and rheumatoid arthritis, etc. | [Synthesis]
Preparation Example 1: General procedure for the synthesis of 2-bromo-5-methylaniline
1. 4-Bromo-3-nitrotoluene (60.35 g, 279 mmol), 5 wt% platinum-carbon catalyst (1.09 g, 0.28 mmol), and triethylamine (112.93 g, 1116 mmol) were added sequentially to the reaction flask.
2. the reaction mixture was heated to 100 °C and 99% formic acid (42.39 g, 921 mmol) was added slowly and dropwise over a period of 20 minutes.
3. The reaction temperature was maintained with continuous stirring for 12 hours.
4. Upon completion of the reaction, cooled to room temperature, ethyl acetate (100 mL) and water (100 mL) were added to the reaction mixture with thorough stirring.
5. Filter through diatomaceous earth to remove the platinum carbon catalyst.
6. Add ethyl acetate (200 mL) and water (100 mL) to the filtrate and extract.
7. The organic phase was separated and washed with deionized water (300 mL x 3 times).
8. The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to afford the target product 2-bromo-5-methylaniline (51.30 g, 276 mmol) in 99% yield.
9. The structure of the product was confirmed by 1H-NMR (270 MHz, CDCl3): δ (ppm) 7.260 (1H, d), 6.583 (1H, ... (data not provided in full)). | [References]
[1] Patent: US2003/191325, 2003, A1. Location in patent: Page/Page column 8 [2] Patent: EP1820799, 2007, A1 [3] Patent: WO2006/51851, 2006, A1. Location in patent: Page/Page column 59-60 [4] Patent: WO2012/65062, 2012, A1. Location in patent: Page/Page column 89-90 [5] Journal of Fluorine Chemistry, 2002, vol. 116, # 2, p. 173 - 179 |
|
|